Cutaneous leishmaniasis in Iraq

Journal of Infection in Developing Countries

Volumn 3, Issue 2, 2009, Pages 123-129

  AlSamarai, Abdulghani Mohamad ^a   AlObaidi, Hussein Saher ^a  

^a TIKRIT UNIVERSITY   (Iraq)

Author keywords

Alhaweja; Epidemiology; Iraq; Leishmaniasis; Secondary infections

Indexed keywords

IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGE; ANTIBODY DETECTION; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; BLOOD SAMPLING; CHILD; CLINICAL EXAMINATION; CONTROLLED STUDY; DERMATOLOGY; DISEASE COURSE; FEMALE; GENERAL HOSPITAL; GIEMSA STAIN; HEALTH SURVEY; HUMAN; INCIDENCE; IRAQ; LEISHMANIA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PARASITE IDENTIFICATION; PRESCHOOL CHILD; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SKIN BIOPSY; SKIN CULTURE; SKIN DEFECT; SKIN LEISHMANIASIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; VENOUS BLOOD;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 66249106397     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.59     Document Type: Article

References (31)

1. CDC (2004) Update CL in US. Military personnel. Southwest/Central Asia, 2002-2004. MMWR 53:264-265.
2. Hepburn NC (2003) Cutaneous leishmaniasis: an overview. JPGM 49:50-54.
3. Markle WH and Makhoul K (2004) Cutaneous leishmaniasis Recognition and Treatment. American Family Physician. 69: 1-9.
4. Ashford RW, Desjeux P, de Raadt P (1992) Estimation of population at risk of infection and number of cases of leishmaniasis. Parasitol Today 8:104-105.
5. WHO (2003) Communicable Disease Working Group on Emergencies, HQ Division of Communicable Disease Control, EMRO, WHO OFFICE, Baghdad. WHO Office, Baghdad. Communicable Disease Toolkit, IRAQ CRISIS. WHO 2003:39-44. www.who.int/diseasecontrol_emergencies/toolkits/ Iraq∥ofile_ok.pdf.
6. Arfan B, Rahman S (2006) Correlation of clinical, histopathological, and microbiological finding in 60 cases of cutaneous leishmaniasis. IJDVL 72:28-32.
7. Singh S and Sivakumar R (2003) Recent advances in the diagnosis of leishmaniasis. JPGM 55-60.
8. Ramirez JR, Agudelo S, Muskus C, et al. (2000) Diagnosis of cutaneous leishmaniasis in Colombia: the sampling site within lesions influences the sensitivity of parasitologic diagnosis. J Clin Microbiol 38:3768-3773.
9. WHO Expert committee (1984) epidemiological aspects. In: Control of the leishmaniasis. World Health Organization, Technical Report Series 701:2-4.
10. Alaa NH (2002) Epidemiology of skin diseases in Tikrit and vicinity: a community based study. M Sc thesis, Tikrit University College of Medicine.
11. Murtada SJ (2001) Epidemiology of skin diseases in Kirkuk. MSc thesis, Tikrit University College of Medicine,
12. Alsamarai AGM. Prevalence of Skin Diseases in Samara, Iraq. MEJIM. In press.
13. Faulde M, Schrader J, Heyl G, Amirih M (2008) Differences in transmission seasons as an epidemiological tool for characterization of anthroponotic and zoonotic cutaneous leishmaniasis in northern Afghanistan. Acta Tropica 105:131-138.
14. Jourquera A, Ledezma E, Sousa L, et al. (1998) Epidemiologic characterization of American cutaneous leishmaniasis in an endemic region of Eastern Veezula. Am J Trop Med Hyg 58:589-593.
15. Akcali C, Culha G, Inaloz HS, et al. (2007) Cutaneous leishmaniasis in Hatay. J Turk Acad Dermatol 1:1-5.
16. AL-Obaidi HS (2000) Microbiological & Pharmacological studies with a Trial of vaccination against cutaneous leishmaniasis. PhD Thesis submitted to Collage of Medicine, University of Tikrit.
17. Sarhan ER. (1998) Study on Epidemiology of Cutaneous leishmaniasis in Baghdad. MSc Thesis submitted to College of Medicine, University of Baghdad.
18. Sharifi I, Ferkeri AR and Aflatonian MR (1998) Cutaneous leishmaniasis in primary school children in the South-eastern Iranian city of Bam, 1994-1995. Bull. WHO 76: 289-293.
19. Talari SA, Shajari G, Talaei R (2006) Clinical finding of cutaneous leishmaniasis as a new focus of Iran. Internet J Infec Dis 1 (2).
20. AL-Zaidawi KA (1997) New approach for treatment of cutaneous leishmaniasis by manitol. Diploma dissertation, College of Medicine, University of Tikrit, Iraq.
21. Hussian AK (1993) Intra-lesional therapy of CL with hypertonic sodium chloride solution. Diploma thesis submitted to Drmatology & Venerology Dep. College of Medicine, University of Baghdad.
22. AL-Gorban HA. (1996) Comparison of the intralesional therapy of cutaneous leishmaniasis. A dissertation submitted to the College of Medicine, Univesity of Tikrit. As a requirement for the degree of Diploma in Primary of Health care.
23. WHO (2000) Leishmaniasis and Leishmania/HIV co-infection. In: WHO report on global surveillance of epidemic prone infectious diseases, WHO/ CDS/CSR/ISR/2000.1.PP:121-127.
24. Philippon E, Gramond C, Chouc C. (2005) Leishmaniasis. Med Trop 65:419-420.
25. Uzun S, Uslular C, Yucel A, Acar MA, Ozpoyraz M, Memisoglu HR (1999) Cutaneous leishmaniasis: evaluation of 3074 cases in the Cukurova region of Turkey. Br J Dermatol 140:347-350.
26. Gurel MS, Ulukanligil M, Ozbilge H (2002) Cutaneous Leishmaniasis in Sanliurfa: epidemiologic and clinical features of the last four years (1997-2000) Int J Dermatol 41:32-37.
27. Navin T, Arana F, Demerida A, Arana B, Castillo L, Silvers D (1990) Cutaneous Leishmaniasis in Guatemala: comparison of diagnosis methods. Am J Trop Med Hyg 42:36-42.
28. Weigle K, Dedavalos M, Heredia P, Molineros R, Saravia N, D'Alessandro A (1978) Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods. Am J Trop Med Hyg 36:489-496.
29. Sharquie KE, Hassan AS, Hassan SA, Al-Hamami IA (2002) Evaluation of diagnosis of cutaneous leishmaniasis by direct smear, culture and histopathology. Saudi Med J 23:925-928.
30. Chaudhuri G, Chang KP (1988) Acid protease activity of a major surface membrane glycoprotein (gp63) from Leishmania mexicana promastigotes. Mol Bioch Parasitol 27:43-52.
31. Ziaie H, Sadeghian G (2008) Isolation of bacteria causing secondary bacterial infections in the lesions of cutaneous leishmaniasis. Indian J Dermatology. 53:129-131.